News
India's one-shot dengue vaccine 'DengiAll' reaches 70% enrolment in Phase III trials across 20 national sites.
In a letter to the Rajya Sabha deputy chairman Harivansh, Kharge said he was shocked and astonished to see CISF personnel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback